For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Link below for more detailed information: Product Overview: Retatru/Cagrilintide is a dual-compound research peptide combining Retatru, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways, and Cagrilintide, an amylin analog
Lincoln Park or Illinois telehealth
The longer the treatments are continued, the more noticeable the brightness and reduction of pigmented lesions on the skin
Patients already using PRP for hair thinning may see compounding benefits from a KLOW cycle, since GHK-Cu supports the same follicular regeneration pathways from the inside